Finance

Beta
Lists
RNTX:NASDAQ
Rein Therapeutics Inc
$1.01
+4.27%
(+0.041) 1D
$1.03
+1.98% (+0.020)
After hours
Closed: Jun 24, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RNTX...
Open
$0.97
High
$1.01
Low
$0.95
Mkt. cap
85.39M
Avg. vol.
588.69K
Volume
578.38K
52-wk high
$2.18
52-wk low
$0.86
EPS
-$1.78
Beta
1.35
Shares outstanding
85.54M
No. of employees
10
Open
$0.97
High
$1.01
Low
$0.95
Mkt. cap
85.39M
Avg. vol.
588.69K
Volume
578.38K
52-wk high
$2.18
52-wk low
$0.86
EPS
-$1.78
Beta
1.35
Shares outstanding
85.54M
No. of employees
10
News stories
From sources across the web
About Rein Therapeutics Inc
CEO-
Employees10
Founded2001
HeadquartersAustin, Texas, United States
SectorBiotechnology
Websitereintx.com
Analyst Ratings
Based on 1 analyst giving stock ratings to RNTX in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for RNTX in the last 3 months.
Highest
Current $1.01
$8.00 (+692.08%)
Average
$8.00 (+692.08%)
Lowest
$8.00 (+692.08%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Brandon Folkes
H.C. Wainwright
Buy
Reiterated
$8.00
+692.1%
06/01/2026
Kemp Dolliver
Brookline Capital Markets
Hold
Downgraded
-
-
01/21/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.29M
1.68M
2.00M
3.07M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.58M
3.81M
1.96M
2.16M
Operating expense
6.87M
5.49M
3.96M
5.23M
Total operating expenses
6.87M
5.49M
3.96M
5.23M
Operating income
-6.87M
-5.49M
-3.96M
-5.23M
Other non operating income
49.00K
-89.00K
-20.00K
-608.00K
EBT including unusual items
-6.82M
-5.58M
-32.68M
-5.84M
EBT excluding unusual items
-6.82M
-5.58M
-3.98M
-5.84M
Income tax expense
-
-
-712.00K
-
Effective tax rate
-
-
2.18%
-
Other operating expenses
-
-
-
-
Net income
-6.82M
-5.58M
-31.97M
-5.84M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.87M
-5.49M
-3.96M
-5.23M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer